Clinical Trial Update: The Efficacy of Spironolactone in Patients With Resistant Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating spironolactone for resistant hypertension was terminated; the update does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Hypertension | Phase 2 | Status: TERMINATED